antibody

(redirected from Anticardiolipin antibody)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to antibody

References in periodicals archive ?
IgM type of anticardiolipin antibody titer was high, but this was not a concern because she had frequent abortion history.
Their study results were found to mirror the results noted in the 2003 College of American Pathologists ACL-B survey for anticardiolipin antibody proficiency testing where an 80% consensus was reached for only five of the nine (55%) samples distributed for testing.
Anticardiolipin antibody of IgG or IgM isotype present in medium or high titer in serum or plasma on two occasions at least 12 weeks apart.
2) Of these, RF was found in 38 to 71% of patients, (2,4,5) antinuclear antibody in 10 to 41%, (2,3,4,5) antismooth muscle antibody in 9 to 22%, antithyroglobulin antibody in 7 to 14%, anti-LKM1 antibody in 5%, and anticardiolipin antibody in up to 44%.
Laboratory results showed a highly positive lupus anticoagulant test, leukopenia, elevated anticardiolipin antibody, a positive antinuclear antibody test, negative rheumatoid factor, and below-normal protein C levels.
IgM anticardiolipin antibody was repeated after 12 weeks and it came out to be positive (42 MPL units >99th percentile), Lupus anticoagulant test was negative after 12 weeks.
Anticardiolipin antibody was tested by enzyme- linked immunosorbent assay (ELISA) for cardiolipin.
IgG and IgM anticardiolipin antibodies in patients with lupus and anticardiolipin antibody associated clinical syndromes.
Distinguishing beta2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween-20.
She had a history of anticardiolipin antibody syndrome, diagnosed originally in 1993 after 2 spontaneous abortions.
Yes, warfarin is effective in the secondary prevention of venous thromboembolic events (VTEs) for patients positive for lupus anticoagulant or anticardiolipin antibody (also known as antiphospholipid antibodies [aPL]) (strength of recommendation [SOR]: B, single cohort study, extrapolation from other RCTs).